Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications
Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily attributed to excessive fibrin accumulation in the blood vessels, usually consequential in thrombosis. Numerous methodologies including the use of anti-coagulants, anti-platelet drugs, surgical operations and fi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/13/11/1880 |
| _version_ | 1797508805727092736 |
|---|---|
| author | Chhavi Sharma Alexander Osmolovskiy Rajni Singh |
| author_facet | Chhavi Sharma Alexander Osmolovskiy Rajni Singh |
| author_sort | Chhavi Sharma |
| collection | DOAJ |
| description | Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily attributed to excessive fibrin accumulation in the blood vessels, usually consequential in thrombosis. Numerous methodologies including the use of anti-coagulants, anti-platelet drugs, surgical operations and fibrinolytic enzymes are employed for the dissolution of fibrin clots and hence ameliorate thrombosis. Microbial fibrinolytic enzymes have attracted much more attention in the management of cardiovascular disorders than typical anti-thrombotic strategies because of the undesirable after-effects and high expense of the latter. Fibrinolytic enzymes such as plasminogen activators and plasmin-like proteins hydrolyse thrombi with high efficacy with no significant after-effects and can be cost effectively produced on a large scale with a short generation time. However, the hunt for novel fibrinolytic enzymes necessitates complex purification stages, physiochemical and structural-functional attributes, which provide an insight into their mechanism of action. Besides, strain improvement and molecular technologies such as cloning, overexpression and the construction of genetically modified strains for the enhanced production of fibrinolytic enzymes significantly improve their thrombolytic potential. In addition, the unconventional applicability of some fibrinolytic enzymes paves their way for protein hydrolysis in addition to fibrin/thrombi, blood pressure regulation, anti-microbials, detergent additives for blood stain removal, preventing dental caries, anti-inflammatory and mucolytic expectorant agents. Therefore, this review article encompasses the production, biochemical/structure-function properties, thrombolytic potential and other surplus applications of microbial fibrinolytic enzymes. |
| first_indexed | 2024-03-10T05:09:06Z |
| format | Article |
| id | doaj.art-8704556d2698449b9639a75d498d820d |
| institution | Directory Open Access Journal |
| issn | 1999-4923 |
| language | English |
| last_indexed | 2024-03-10T05:09:06Z |
| publishDate | 2021-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj.art-8704556d2698449b9639a75d498d820d2023-11-23T00:59:01ZengMDPI AGPharmaceutics1999-49232021-11-011311188010.3390/pharmaceutics13111880Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical ApplicationsChhavi Sharma0Alexander Osmolovskiy1Rajni Singh2Amity Institute of Microbial Technology, Amity University Uttar Pradesh, Noida 201313, IndiaDepartment of Microbiology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, RussiaAmity Institute of Microbial Technology, Amity University Uttar Pradesh, Noida 201313, IndiaCardiac disorders such as acute myocardial infarction, embolism and stroke are primarily attributed to excessive fibrin accumulation in the blood vessels, usually consequential in thrombosis. Numerous methodologies including the use of anti-coagulants, anti-platelet drugs, surgical operations and fibrinolytic enzymes are employed for the dissolution of fibrin clots and hence ameliorate thrombosis. Microbial fibrinolytic enzymes have attracted much more attention in the management of cardiovascular disorders than typical anti-thrombotic strategies because of the undesirable after-effects and high expense of the latter. Fibrinolytic enzymes such as plasminogen activators and plasmin-like proteins hydrolyse thrombi with high efficacy with no significant after-effects and can be cost effectively produced on a large scale with a short generation time. However, the hunt for novel fibrinolytic enzymes necessitates complex purification stages, physiochemical and structural-functional attributes, which provide an insight into their mechanism of action. Besides, strain improvement and molecular technologies such as cloning, overexpression and the construction of genetically modified strains for the enhanced production of fibrinolytic enzymes significantly improve their thrombolytic potential. In addition, the unconventional applicability of some fibrinolytic enzymes paves their way for protein hydrolysis in addition to fibrin/thrombi, blood pressure regulation, anti-microbials, detergent additives for blood stain removal, preventing dental caries, anti-inflammatory and mucolytic expectorant agents. Therefore, this review article encompasses the production, biochemical/structure-function properties, thrombolytic potential and other surplus applications of microbial fibrinolytic enzymes.https://www.mdpi.com/1999-4923/13/11/1880microbial fibrinolytic enzymesenzyme productionenzyme purificationcharacterisationstructural-functional attributesthrombolytic potential |
| spellingShingle | Chhavi Sharma Alexander Osmolovskiy Rajni Singh Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications Pharmaceutics microbial fibrinolytic enzymes enzyme production enzyme purification characterisation structural-functional attributes thrombolytic potential |
| title | Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications |
| title_full | Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications |
| title_fullStr | Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications |
| title_full_unstemmed | Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications |
| title_short | Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications |
| title_sort | microbial fibrinolytic enzymes as anti thrombotics production characterisation and prodigious biopharmaceutical applications |
| topic | microbial fibrinolytic enzymes enzyme production enzyme purification characterisation structural-functional attributes thrombolytic potential |
| url | https://www.mdpi.com/1999-4923/13/11/1880 |
| work_keys_str_mv | AT chhavisharma microbialfibrinolyticenzymesasantithromboticsproductioncharacterisationandprodigiousbiopharmaceuticalapplications AT alexanderosmolovskiy microbialfibrinolyticenzymesasantithromboticsproductioncharacterisationandprodigiousbiopharmaceuticalapplications AT rajnisingh microbialfibrinolyticenzymesasantithromboticsproductioncharacterisationandprodigiousbiopharmaceuticalapplications |